Eaton Vance Enhanced Equity Income Fund II (EOS) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Eaton Vance Enhanced Equity Income Fund II (EOS).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $20.95

Daily Change: +$0.31 / 1.48%

Range: $20.78 - $21.08

Market Cap: $1,109,574,912

Volume: 62,254

Performance Metrics

1 Week: 6.08%

1 Month: -5.12%

3 Months: -14.70%

6 Months: -7.59%

1 Year: 5.92%

YTD: -12.53%

Details

Eaton Vance Enhanced Equity Income Fund II is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets of the United States. It seeks to invest in the stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of mid-cap and large-cap companies. It generates current earnings from option premiums by selling covered call options on a substantial portion of its portfolio. The fund benchmarks the performance of its portfolio against the Russell 1000 Growth Index, the CBOE S&P 500 BuyWrite Index, and the CBOE NASDAQ-100 BuyWrite Index. Eaton Vance Enhanced Equity Income Fund II was formed on January 31, 2005 and is domiciled in the United States.

Selected stocks

Crinetics Pharmaceuticals, Inc. (CRNX)

Alignment Healthcare, Inc. (ALHC)

Molecular Partners AG (MOLN)